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Creutzfeldt-Jakob disease (CJD) is a transmissible spon-
giform encephalopathy or prionic disease characterized 
by accumulation of abnormal prionic protein (PrPsc) asso-
ciated to spongiform degeneration of the brain1. Although 
rare, CJD is the most common prionic disease in humans 
with an incidence rate around 1/1,000,0002. Historically, 
it was first described as a dementing illness by Jakob in 
19213-5. CJD is a rapidly progressive dementia syndrome as-
sociated to pyramidal, extrapyramidal and visual signs and 
symptoms. About 90% of the affected individuals devel-
op movement disorders throughout the course of CJD and 
myoclonus is the most common disorder seen in 82 to 
100% of cases6. Other movement disorders less frequent-
ly seen include: dystonia, choreoathetosis, tremors, and 
parkinsonian syndrome. The rate of movement disorders 
increases as CJD progresses and they are less frequently 
seen in the early stages of disease. Parkinsonism is rarely 
found as an early manifestation of CJD7. CJD can be classi-
fied as sporadic, genetic, iatrogenic and variant form2,4,5,8. 
It is characterized by fast disease progression with a mean 
survival rate of four months after diagnosis. Two-thirds of 
patients with CJD die within six months after symptom on-
set. Some patients at early stages can progress to a state 
of akinetic mutism1,2. Dementia with Lewy bodies (DLB) is a 
dementia syndrome associated to parkinsonism with little 
response to L-DOPA, cognitive fluctuations, visual halluci-
nations, and hypersensitivity to neuroleptics. It has a slow-
er course but life expectancy is 5 to 8 years after symptom 
onset. DLB is the second most frequent cause of neuro-
degenerative dementia and its main differential diagnosis 
are with Alzheimer’s disease, Parkinson’s disease and some 
forms of atypical parkinsonism9,10. In vivo diagnostic confir-
mation for both CJD and DLB is a challenge since the gold 
standard for their diagnosis is pathology examination11. 
We report a case of CJD that was firstly clinically diag-
nosed as DLB, highlighting the occurrence of severe par-
kinsonian syndrome associated to neuroleptic use.
CaSe 
A 65-year-old male patient with no clinical comorbidities 
or relevant family history developed short-term memory loss, 
episodes of mental confusion, visual hallucinations and inver-
sion of the sleep-awake rhythm that started three months pri-
or to his first medical evaluation. The patient’s symptoms pro-
gressively aggravated and he was medicated with a neuropletic 
drug (risperidone 1 mg at night) for controlling behavioral dis-
orders. Three days after the introduction of risperidone the pa-
tient developed bilateral symmetrical rigid-akinetic parkinsonian 
syndrome showing high severity scores (Hoehn & Yahr=4, Uni-
fied Parkinson’s Disease Rating Scale part III=60, Schwab & Eng-
land=20%) that made him bedridden and unable to eat indepen-
dently. He was admitted to the hospital for investigation of his 
parkinsonian syndrome associated to behavioral-cognitive symp-
toms and a diagnostic hypothesis of DLB was made. Although 
risperidone was discontinued and biperiden was given at a dose 
of up to 16 mg a day, the patient did not show any symptom re-
lief and developed myoclonus in the face and extremities. Sero-
logical (HIV, syphilis, hepatitis B and C) and rheumatology tests, 
and vitamin B12 and folic acid measurements were all normal. 
Brain magnetic resonance imaging (MRI) showed abnormal sig-
nal intensity in putamen and caudate nucleus and in the surface 
area of cortical gyri bilaterally in FLAIR and diffusion imaging se-
quences (Fig 1). The electroencephalogram (EEG) revealed gen-
eralized short periodic triphasic wave complexes (Fig 2) and 14-
3-3 protein was detected in the cerebrospinal fluid (CSF). Since 
these findings were all consistent with CJD, the initial diagnosis 
of DLB was changed.
During his admission the patient progressed with apathy, dif-
ficulties with understanding and expression, akinetic mutism and 
required enteral feeding, tracheostomy and respiratory support. 
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The patient died seven months after symptom onset due to re-
spiratory complications. 
Informed consent to allow data publication was signed by 
the patient responsible relative.
diSCuSSion
The diagnostic hypothesis of CJD should be suggested 
in any patient aged between 55 and 65 years with his-
tory of rapidly progressive dementia syndrome associ-
ated to pyramidal, extrapyramidal, cerebellar or visual 
symptoms1,2. Some clinical presentations of CJD can 
mimic a wide range of typical and atypical parkinsonian 
syndromes. Lida et al. reported the association of Par-
kinson’s disease and a sporadic form of CJD in a 64-year-
old female patient with dementia and progressive par-
kinsonian symptoms over 4 years. Pathology examination 
showed findings consistent with both diseases12. Kawasaki 
et al. were the first to report a case of sporadic CJD in 
a 64-year-old male patient with a 53-month history of 
progressive dementia syndrome associated with clinical 
findings of progressive supranuclear palsy and dysauto-
nomia13. One more case was reported by Shimamura et 
al. and two other cases by Josephs et al. showing vertical 
supranuclear ophthalmoplegia and symmetrical parkin-
sonism with predominant axial rigidity and disease course 
between 10 and 29 months14,15. Cannard et al. reported a 
case of a patient with CJD and atypical history of corti-
cobasal degeneration16. On the other hand, patients with 
rapidly progressive dementia manifestations associated to 
parkinsonian symptoms have been misdiagnosed as CJD 
but subsequently they were confirmed as DLB cases in the 
pathology examination17.
DLB has several clinical characteristics in common 
with CJD such as cognitive deficit, and movement and be-
havioral disorders11,18. These clinical features may lead to 
diagnostic confusion at early stages in both diseases and 
additional exams may be necessary to provide diagnostic 
confirmation. DLB is diagnosed according to clinical crite-
ria18 and supported by occipital hypoperfusion on SPECT; 
a definite diagnosis can only be established by autopsy9. 
On the other hand, CJD is supported by cerebrospinal flu-
id findings (positive 14-3-3 protein on CSF), brain magnetic 
resonance imaging (hyperintensity of the basal ganglia)19,20, 
but a definite diagnosis can also only be made by autopsy.
Hypersensitivity to neuroleptics leading to or aggra-
vating parkinsonian symptoms is a clinical diagnostic fea-
ture of DLB. In the case reported here, the patient had 
severe manifestations of parkinsonism while taking low-
dose risperidone with no relief after its discontinuation. 
We believe his hypersensitivity was due to preexisting 
anatomical and functional alterations in the basal nuclei, 
as shown in Figure 1, caused by CJD. This hypersensitivity 
to neuroleptics might be a major factor leading to diag-
nostic confusion between DLB and CJD as Lemstra et al.18 
pointed out in their study.
In conclusion, there can be diagnostic confusion be-
tween DLB and CJD in patients with rapidly progressive de-
mentia syndrome associated to extrapyramidal symptoms, 
behavioral disorders, and hypersensitivity to neuroleptics. 
The detection of 14-3-3 protein in CSF, abnormal signal 
intensity in the basal nuclei in brain MRI and short disease 
course are findings suggestive of CJD17,19,21,22. The finding 
Fig 1. Axial brain MRI showing in the diffusion sequence hypersig-
nal in the right caudate nucleus and frontal, temporal and occipi-
tal cortical gyri.
Fig 2. Electroencephalogram showing generalized short periodic tri-
phasic wave complexes (arrow)
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of a periodic pattern in EEG, although regarded highly 
sensitive to CJD, can also be seen in patients with DLB23,24 
and should not be used as a single tool for diagnosis.
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